✦ LIBER ✦

An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis

✍ Scribed by D. E. J. JONES; J. L. NEWTON

Book ID: 108604854
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 516 KB
Volume: 25
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.03223.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Initiating treatment with modafinil for

Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies

✍ Michael J. Thorpy; Jonathan R. L. Schwartz; Ruzica Kovacevic-Ristanovic; Roza Ha 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 165 KB

An open, randomized, controlled study of

An open, randomized, controlled study of transdermal hormone replacement therapy on the rate of bone loss in primary biliary cirrhosis

✍ S. Ormarsdóttir; H. Mallmin; T. Naessén; M. Petrén-Mallmin; U. Broomé; R. Hultcr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Open-label study of adjunct modafinil fo

Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors

✍ Numan Konuk; Nuray Atasoy; Levent Atik; Ömer Akay 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 239 KB

American association for the study of li

American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis

✍ Marina G. Silveira; Elizabeth M. Brunt; Jenny Heathcote; Gregory J. Gores; Keith 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

A group of multidisciplinary experts on primary biliary cirrhosis (PBC) and its complications convened on May 31, 2009, under the aegis of the American Association for the Study of Liver Diseases (AASLD) in order to identify the most appropriate design and endpoints for clinical trials of PBC based

Expression of co-stimulatory factor B7-2

Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: an immunohistochemical study

✍ Tsuneyama, Koichi; Harada, Kenichi; Yasoshima, Mitsue; Kaji, Kyosuke; Gershwin, 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 371 KB 👁 2 views

Co-stimulatory factors B7-1 (CD80) and B7-2 (CD86) and their ligands, including CD28, are important for the efficient presentation and persistence of an antigen-specific immune reaction. Hitherto, there has been a paucity of data on the roles of such co-stimulatory factors in immune-mediated biliary

Seasonal variation in the patient diagno

Seasonal variation in the patient diagnosis of primary biliary cirrhosis: Further evidence for an environmental component to etiology

✍ Richard J.Q. McNally; Peter W. James; Samantha Ducker; Oliver F.W. James 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB